Mars Finance reports that according to Gate Market Data, the U.S. stock market opened with the Dow Jones Industrial Average down 0.33%, the S&P 500 down 0.15%, and the Nasdaq Composite down 0.13%. Novo Nordisk (NVO.N) plummeted 15.65%, with the company stating that its weight-loss drug Cagrisema was less effective in trials compared to Eli Lilly’s Zepbound. Eli Lilly (LLY.N) opened up 3.86%.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
U.S. stocks open lower, Dow Jones down 0.33%, Novo Nordisk plunges 15.65%
Mars Finance reports that according to Gate Market Data, the U.S. stock market opened with the Dow Jones Industrial Average down 0.33%, the S&P 500 down 0.15%, and the Nasdaq Composite down 0.13%. Novo Nordisk (NVO.N) plummeted 15.65%, with the company stating that its weight-loss drug Cagrisema was less effective in trials compared to Eli Lilly’s Zepbound. Eli Lilly (LLY.N) opened up 3.86%.